ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase III, Randomized, Double Blind Trial Low Dose Tamoxifen Versus Placebo in Hormone Replacement Therapy (HRT) Users (HOT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01579734
Recruitment Status : Active, not recruiting
First Posted : April 18, 2012
Last Update Posted : January 31, 2018
Sponsor:
Information provided by (Responsible Party):
European Institute of Oncology

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : December 2018
  Estimated Study Completion Date : December 2019